Fulgent Genetics (FLGT) Total Current Liabilities (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Total Current Liabilities for 11 consecutive years, with $85.0 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities rose 16.55% to $85.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85.0 million through Dec 2025, up 16.55% year-over-year, with the annual reading at $85.0 million for FY2025, 16.55% up from the prior year.
- Total Current Liabilities hit $85.0 million in Q4 2025 for Fulgent Genetics, up from $72.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $196.5 million in Q1 2021 to a low of $61.4 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $95.2 million across 5 years, with a median of $78.9 million in 2023.
- Biggest five-year swings in Total Current Liabilities: skyrocketed 3282.62% in 2021 and later plummeted 49.17% in 2023.
- Year by year, Total Current Liabilities stood at $105.3 million in 2021, then decreased by 16.34% to $88.1 million in 2022, then decreased by 17.13% to $73.0 million in 2023, then fell by 0.16% to $72.9 million in 2024, then increased by 16.55% to $85.0 million in 2025.
- Business Quant data shows Total Current Liabilities for FLGT at $85.0 million in Q4 2025, $72.4 million in Q3 2025, and $71.3 million in Q2 2025.